Loading…
Natural cannabinoids: Templates for drug discovery
Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3 n-pentyl side chain in the most prominently represented cannabinoids from Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3 n-propyl sid...
Saved in:
Published in: | Life sciences (1973) 2005-12, Vol.78 (5), p.454-466 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recent studies have elucidated the biosynthetic pathway of cannabinoids and have highlighted the preference for a C-3
n-pentyl side chain in the most prominently represented cannabinoids from
Cannabis sativa and their medicinally important decarboxylation products. The corresponding C-3
n-propyl side chain containing cannabinoids are also found, although in lesser quantities. Structure–activity relationship (SAR) studies performed on Δ
9-tetrahydrocannabinol (Δ
9-THC), the key psychoactive ingredient of
Cannabis, and its synthetic analogues have identified the C-3 side chain as the key pharmacophore for ligand affinity and selectivity for the known cannabinoid receptors and for pharmacological potency. Interestingly, the terminal
n-pentyl saturated hydrocarbon side chain of endocannabinoids also plays a corresponding crucial role in conferring similar properties. This review briefly summarizes the biosynthesis of cannabinoids and endocannabinoids and focuses on their side chain SAR. |
---|---|
ISSN: | 0024-3205 1879-0631 |
DOI: | 10.1016/j.lfs.2005.09.014 |